Compare · head to head
Daewoong Pharmaceutical vs Ilyang Pharmaceutical
Ilyang Pharmaceutical ranks higher overall — 360 rank 30 vs 27.
Ilyang Pharmaceutical leads on Quality (68 vs 46). Daewoong Pharmaceutical leads on Growth (52 vs 40). The two are close on Value, Safety and Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | South Korea | South Korea |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | Medium | Small |
| ISIN | KR7069620003 | KR7007570005 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 27 | 30 |
| Value | 48 | 48 |
| Quality | 46 | 68 |
| Growth | 52 | 40 |
| Safety | 32 | 31 |
| Sentiment | 46 | 43 |
| Quality details | ||
| Profitability | 65 | 64 |
| Cash Truth | 27 | 72 |
Daewoong Pharmaceutical vs PharmGen ScienceDaewoong Pharmaceutical vs Kukje PharmaDaewoong Pharmaceutical vs Dongwha PharmDaewoong Pharmaceutical vs Aprogen BiologicsAdd a third stock →
Full analyses: Daewoong Pharmaceutical · Ilyang Pharmaceutical
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100